US HB2074 | 2019-2020 | 116th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 50-4)
Status: Introduced on April 3 2019 - 25% progression, died in committee
Action: 2019-04-04 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 3 2019 - 25% progression, died in committee
Action: 2019-04-04 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.
Title
Gluten in Medicine Disclosure Act of 2019
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2019-04-04 | House | Referred to the Subcommittee on Health. |
| 2019-04-03 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-04-03 | House | Introduced in House |
Same As/Similar To
SB3021 (Same As) 2019-12-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Consumer affairs
Drug safety, medical device, and laboratory regulation
Grain
Health
Nutrition and diet
Prescription drugs
Drug safety, medical device, and laboratory regulation
Grain
Health
Nutrition and diet
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/2074/all-info |
| Text | https://www.congress.gov/116/bills/hr2074/BILLS-116hr2074ih.pdf |
